Chris Nolet
CIK 1782814 · last filed 2025-07-03
Chris Nolet is a corporate insider who has filed 22 SEC Form 4 insider transactions across 5 companies since 2019. The most recent filing, for JSPRW, was dated Jul 3, 2025. Current disclosed insider exposure totals $436 across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$436
5
22
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| JSPRW | Director | 32,500 | $0.01 | $436 | $0 | 5 | 2025-07-03 |
| AVBP | Director | — | $30.54 | — | $0 | 2 | 2025-06-20 |
| Revance Therapeutics, Inc. (RVNC) Delisted | Director | 0 | $3.65 | $0 | $0 | 8 | 2025-02-06 |
| POLARITYTE, INC. (PTE) Delisted | Director | 14,403 | $0.24 | $3.5K | $0 | 4 | 2023-01-17 |
| Viela Bio, Inc. (VIE) Delisted | Director | — | — | — | $0 | 2 | 2021-03-15 |
Recent Filings
22 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-07-03 | JSPRW | Grant (A) | — | $0 | EDGAR |
| 2025-06-20 | AVBP | Grant (A) | — | $0 | EDGAR |
| 2025-02-06 | Revance Therapeutics, Inc. (RVNC) Delisted | Mixed | −43,606 | -$104.4K | EDGAR |
| 2024-06-10 | JSPRW | Grant (A) | — | $0 | EDGAR |
| 2024-05-03 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | +15,000 | $0 | EDGAR |
| 2024-01-29 | AVBP | Grant (A) | — | $0 | EDGAR |
| 2023-06-08 | JSPRW | Grant (A) | — | $0 | EDGAR |
| 2023-05-05 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | +3,534 | $0 | EDGAR |
| 2023-01-17 | POLARITYTE, INC. (PTE) Delisted | Exer (M) | −36,497 | $0 | EDGAR |
| 2022-10-13 | JSPRW | Grant (A) | +32,500 | $0 | EDGAR |